| DE-BOUGANIN
|
|
|
Journal of Immunotherapy
Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin
|
2009 |
|
Preclinical Safety Evaluation of BioPharmaceuticals
Chapter 29
Preclinical Safety Evaluation of Immunotoxins |
2008 |
|
Complete regression of ovarian cancer xenografts following treatment with the recombinant immunocytotoxic protein, VB6-845 |
2006 |
|
Recombinant engineering of an Ep-CAM-specific Fab antibody (VB6-845) with de-immunized bouganin |
2005 |
|
De-Immunized Bouganin: An innovative, antibody-directed, cytotoxic payload for a safer and more efficacious treatment of cancer |
2005 |
|
Epitope-Depleted Bouganin: An innovative, antibody-directed, cytotoxic payload for a safer and more efficacious treatment of cancer
|
2005 |
|
